AzTrials
AzTrials

Tobacco CessationNCT07431619

A Web-Based Text Messaging for Tobacco Cessation in Rural Mississippi

A study testing Motivational text messaging for tobacco cessation and Non-specific text messaging in people with Tobacco Cessation, run by University of Mississippi Medical Center.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Cigarette smoking prevalence has decreased to ~12% in 2022; however, over 40 million U.S. adults were current cigarette smokers in the same year. Rural-urban disparities in tobacco use are persistent, with higher tobacco use and lower cessation in rural areas. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Tobacco Cessation
What is being tested?
Motivational text messaging for tobacco cessation and Non-specific text messaging
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
150 participants
Where
No sites listed yet
Study dates
1 Dec 2026to 30 Nov 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • ≥18 years-old
  • resident of rural Mississippi (verified by a ZIP code)
  • not planning to move out of Mississippi during the next 6 months
  • own a personal cellphone with an unlimited texting plan
  • having the intention to quit tobacco and having made at least 1 quit attempt in the past 6 months
  • smokes ≥5 cigarettes per day during the past 6 months (for the cigarette smoking condition)
  • uses SLT ≥3 times per day during the past 6 months (for the SLT condition)
  • concurrent use of cigarettes and SLT on ≥15 days monthly during the past 6 months (for the dual use condition).

Who cannot join

  • a self-report of being diagnosed with or taking medications for severe mental illness
  • refusal to provide informed consent
  • having no intention to quit tobacco
  • currently using electronic cigarettes or pharmacological medications for tobacco cessation
  • currently participating in another RCT.

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Raed A Bahelah, PhD contact

601-815-9523

rbahelah@umc.edu

About this study

Official title: A Randomized Trial of a Web-Based Text Messaging for Tobacco Cessation in Rural Mississippi

Cigarette smoking prevalence has decreased to ~12% in 2022; however, over 40 million U.S. adults were current cigarette smokers in the same year. Rural-urban disparities in tobacco use are persistent, with higher tobacco use and lower cessation in rural areas. Less research has been dedicated to addressing rural-urban tobacco use disparities, perhaps due to logistics, difficulty recruiting and following participants from rural areas, and challenges with conducting clinic-based interventions. Mississippi is one of the states with higher rurality, as 79% of Mississippi counties are classified as rural. Additionally, Mississippi has a higher prevalence of tobacco use and lower cessation rates compared with the national average. Moreover, Mississippi is one of the few states that did not expand Medicaid, which covers comprehensive tobacco cessation services. This may add to the persistent disparity in tobacco use and cessation between rural and urban Mississippians. To overcome these challenges, the investigators propose a randomized clinical trial to test the effectiveness of theory-driven text messaging for tobacco cessation in rural Mississippi among users of cigarettes, smokeless tobacco (SLT), and dual users of cigarettes and SLT. Specifically, this proposal has the following specific aims: (1) To conduct a two-arm, randomized, clinical trial (RCT) of a web-based, text messaging approach for tobacco cessation among cigarette smokers, SLT users and dual users from rural Mississippi; (2) To assess the effectiveness of a web-based, text messaging intervention on tobacco cessation among cigarette smokers, SLT users and dual users; and (3) To identify barriers to and facilitators of tobacco cessation using ecological momentary assessment (EMA). To achieve these aims, a sample of 150 tobacco users (50 cigarette smokers, 50 SLT users, 50 dual users) who intend to quit and have made ≥1 quit attempt in the past 6 months will be recruited via a web-based, crowdsourcing platform (ResearchMatch.org). ResearchMatch.org is a large crowdsourcing platform that facilitates recruitment of a desired research sample from an online panel. Eligible participants will be randomized to intervention and control arms and will be asked to set up a quit date within the first 4 weeks post-intervention. Participants in the intervention arm will receive up to 3 motivational text messages daily during the first 4 weeks, and up to 2 daily during the last 2 weeks. The same frequency will be followed for the control group, but they will receive non-specific text messages. Participants will also receive a daily, midday text message during weeks 1-10 post-intervention to document the barriers and facilitators of tobacco cessation using EMA approach. After week 10 and to the end of 6 months post-intervention, the frequency of EMA texts will be reduced to once per week. Two-way text messaging will be facilitated via a web-based service called Mosio. The investigators will assess prolonged and 7-day point prevalence abstinence at 6 weeks, 3 months, and 6 months post-intervention. This project represents an attempt to test a simple and innovative approach to reducing rural-urban tobacco use disparities and overall tobacco-related morbidity and mortality. The findings can facilitate applying for extramural funding for a larger trial.

Being tested
Motivational text messaging for tobacco cessation, Non-specific text messaging
Keywords
Rural, Text messaging, Smokeless tobacco
Medical subject headings
Tobacco Use Cessation, Tobacco Use

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Motivational text messaging for tobacco cessationBehavioural

    Participants will receive motivational text messaging for tobacco cessation.

  • Non-specific text messagingBehavioural

    Non-specific text messaging

Study groups in NCT07431619
Study groupRoleWhat they receive
Motivational text messagingActive comparatorParticipants will receive motivational text messaging for tobacco cessation
Receives: Behavioral: Motivational text messaging for tobacco cessation
Non-specific text messagingPlacebo comparatorParticipants will receive non-specific text messaging
Receives: Behavioral: Non-specific text messaging

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Prolonged abstinence

    Prolonged abstinence is defined as self-report of not using cigarettes (among cigarette smokers), SLT (among SLT users), and both SLT and cigarettes (among dual users) between baseline and 6 months post-randomization. This outcome will be measured at three time points: 6 weeks, 3 months, and 6 months post-randomization.

    Measured: Baseline to 6 months post-randomization

  2. 7-day point prevalence abstinence

    At each time point (6 weeks, 3 months, and 6 months), participants will complete a survey and self-report their tobacco use during the past 7 days prior to the survey. 7-day point prevalence abstinence is defined as not using cigarettes (among cigarette smokers), SLT (among SLT users), and both SLT and cigarettes (among dual users) during the 7 days prior to the survey.

    Measured: Past 7 days

Secondary outcomes (1)
  1. Prolonged abstinence of all tobacco products

    Prolonged abstinence of all tobacco products, defined as a self-report of complete abstinence from using all tobacco products, including cigarettes, since the quit date at 6 weeks, 3 months, and 6 months post-intervention.

    Measured: Baseline to 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Feb 2026
  2. Study start1 Dec 2026 (estimated)
  3. Primary completion30 Jun 2027 (estimated)
  4. Study completion30 Nov 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
150 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07431619
Sponsor's protocol ID
UMMC-IRB-2024-453
Status last verified
Feb 2026
First submitted
22 Sep 2025
Last updated
24 Feb 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: The dataset will be used as pilot data to apply for larger grants. It is uncertain when the team will be able to obtain external funding based on this pilot dataset, and therefore, sharing IDP is not appropriate.

Questions about this trial

What is this clinical trial studying?

A study testing Motivational text messaging for tobacco cessation and Non-specific text messaging in people with Tobacco Cessation, run by University of Mississippi Medical Center.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 24 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Raed A Bahelah, PhD (601-815-9523, rbahelah@umc.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Prolonged abstinence (time frame: Baseline to 6 months post-randomization). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Feb 2026; AzTrials last refreshed its copy on 1 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in